An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person in their early 50s posted that they are already taking retatrutide (2 mg per week) to lose weight and were recently prescribed three more peptides—tesamorelin, ipamorelin, and MOTS‑c—by an anti‑aging clinic. They asked for starting doses and how to combine them with their current routine, which includes lifting weights three times a week. This is essentially a request for practical dosing advice for adding multiple experimental or prescription peptides on top of an active weight‑loss drug. Retatrutide is a newer drug being tested for weight loss. It acts like certain gut hormones that reduce appetite and slow digestion, helping people eat less and lose weight. It’s in the same general family as semaglutide (the active ingredient in medications like Ozempic and Wegovy), but it targets multiple hormone pathways. Tesamorelin, ipamorelin, and MOTS‑c are different. Tesamorelin is a synthetic peptide used in specific medical settings to raise growth hormone‑releasing hormone and sometimes body composition. Ipamorelin is a peptide that stimulates release of growth hormone too, often used off‑label for muscle or fat goals. MOTS‑c is a small peptide that comes from mitochondria (the cell’s energy factories) and is being studied for effects on metabolism and exercise capacity. None of these are magic bullets; they work through different biological signals. What the evidence actually shows is uneven and limited. Retatrutide has shown significant weight loss in clinical trials, but it’s still under investigation and not widely approved for general use yet. Tesamorelin is approved in some countries for very specific conditions (like HIV‑related fat changes) and has clinical data for that use; its effects on general weight loss in middle‑aged people are not well established. Ipamorelin has some animal and small human studies suggesting it can raise growth hormone a bit, but clear, reliable benefits for fat loss or muscle gain in regular people are not proven. MOTS‑c is mostly at the preclinical and early human study stage; researchers are curious about its metabolic effects, but robust proof in humans is lacking. Importantly, combining these agents hasn’t been tested in large trials, so there’s little reliable data on whether they help more together or create unexpected problems. Why it matters: people trying to lose weight or improve body composition want effective, safe strategies. If you’re already on a powerful appetite‑suppressing peptide like retatrutide, adding other agents that affect hormones or metabolism could change how you respond, possibly helping a bit more or possibly adding side effects. For someone lifting weights and trying to lose another 25–30 pounds, the realistic gains from adding unproven peptides might be modest compared with diet, exercise, and optimizing sleep and stress. Anyone considering this should weigh potential benefits against costs, unknowns, and medical oversight needs. Caveats and risks are important. Combining multiple peptides can raise the risk of side effects like fluid retention, joint pain, changes in blood sugar, or effects on hormone balance. Tesamorelin and ipamorelin affect growth hormone pathways, which can have long‑term risks if misused. MOTS‑c is still experimental, with little safety data in broad populations. Dosage and protocols from anti‑aging clinics vary, and some recommendations come from limited evidence. Pregnant people, those with certain cancers, diabetes, or untreated hormone disorders should be especially cautious. Always discuss with a knowledgeable, independent clinician, get baseline labs, and have follow‑up monitoring rather than relying solely on a clinic’s protocol. Bottom line: you’re mixing a promising but still‑new weight drug with other peptides that are far less proven; exercise caution, get medical monitoring, and don’t expect guaranteed extra weight loss without clear evidence.
Source: r/Peptides